A 1998 study sponsored by the National Institute of Health is the basis of a United States Government patent on the antioxidant and neuroprotective qualities of plant cannabinoids, specifically CBD and the psychoactive THC (tetrahydrocannabinol).
It was found that CBD and THC limit the neurological damage that follows ischemic injuries, such as attacks and traumas. Both compounds were described as of particular application ... in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Visit More https://foodsocietyx.com/cbd-gummies
No comments:
Post a Comment